Select the verticals that power your research. Tell us what you are building. Receive your institution key in seconds and start querying immediately.
Each vertical unlocks a dedicated data stream. Combine them for cross-domain discovery. No credit card required to start.
Bacteria like Pseudomonas putida and Bacillus subtilis reduce metal ions into stable nanoparticles during fermentation. Researchers are using this to produce silver antimicrobial coatings, copper conductive inks, and gold biosensors — all without toxic chemical reagents.
Biogenic silver nanoparticles as small as 23 nm have demonstrated 99% antibacterial efficacy against multidrug-resistant strains.
From penicillin to statins to cyclosporine, the most valuable drugs in history began as microbial metabolites. Today, fermentation-derived APIs command over 46% of the global antibacterial market and drive immunosuppressant pipelines for organ transplantation.
The microbial fermentation APIs market is growing at 6-8% annually, with immunomodulators leading at 8.4% CAGR.
Industrial biotechnology runs on fermentation. Engineered yeast and bacteria produce enzymes for detergents, organic acids for bioplastics, and biofuels for aviation. The difference between a lab curiosity and a commercial strain is often hidden in the literature.
Lactic acid fermentation alone supplies the raw material for polylactic acid (PLA), a bioplastic replacing petroleum-based plastics.
Beyond taste, fermentation transforms food into medicine. Lactic acid bacteria synthesize B vitamins, produce bioactive peptides, and reduce anti-nutrients like phytic acid. The result? Foods that improve iron absorption, lower blood pressure, and support gut health.
Fermented legumes can increase iron bioavailability by up to 300% compared to raw seeds.
Soil microbiome engineering is the next green revolution. Fermentation-derived biofertilizers fix nitrogen without fossil fuel inputs. Biocontrol agents from Bacillus species protect crops without synthetic pesticides. The organisms are the product.
Biofertilizer markets are projected to exceed $4 billion by 2028, driven by regulatory bans on chemical nitrogen.
Vaccine adjuvants, antigen carriers, and cell culture media all trace back to fermentation. Microbial metabolites like polysaccharides and lipopeptides act as immune stimulants. Yeast fermentation produces the hepatitis B surface antigen used in billion-dose vaccines.
Fermentation-derived adjuvants are now in clinical trials for next-generation mRNA and subunit vaccines.
Selected verticals appear below. Complete your profile and receive your institution key instantly.
Copy this key and use it on the Platform to run your first query.
Tier: Scout (2,000 calls/month) | Valid for 30 days.
Upgrade anytime via Enterprise.